You are here: Industry Insights > machine learning

News List

Gilead and AWS collaborate on development and delivery of new medicines for patients expresspharma
December 02, 2021
With AWS as its preferred cloud provider, Gilead uses AWS machine learning and analytics to better inform clinical trial design and advance data-driven decision making, while prioritising patient privacy and security...
The five biggest data challenges for life sciences expresspharma
April 06, 2021
The life sciences industry is at a turning point. To prepare for the future and remain relevant in the ever-evolving business landscape, biopharma companies and medical technology businesses are looking for new ways to create value and make sense of ...
New machine learning technique rapidly analyzes nanomedicines for cancer immunotherapy worldpharmanews
February 20, 2019
With their ability to treat a wide a variety of diseases, spherical nucleic acids (SNAs) are poised to revolutionize medicine.
Vertex invests in Genomics plc as the firms sign research deal pharmatimes
November 26, 2018
UK analytics group Genomics plc has signed a three-year deal with Vertex centred on improving the discovery of targets for precision medicine, and has also raised £25 million to further expand its business.
Epic Sciences gathers $52M for blood tests that match cancer patients to therapies fiercebiotech
September 18, 2018
The platform aims to predict individual patients’ responses to different cancer therapies by identify cancer cells in the bloodstream using computer vision and machine learning.
Using machine learning to see inside live human cells fiercebiotech
May 16, 2018
Looking at human cells isn’t as simple as it sounds, especially when scientists want to examine clearly, in 3D, how multiple structures change over a time while cells are alive.
Daphne Koller, A-list backers unite to create machine learning drug R&D startup fiercebiotech
May 03, 2018
Daphne Koller has unveiled her next goal: improving drug R&D. The ex-Calico AI expert plans to enlist data and machines to address shortcomings in drug discovery and development...